Effect of Topical Application of Atorvastatin Gel Versus Hyaluronic Acid on Immediate Loading Dental Implant in Posterior Maxilla
NCT ID: NCT06976866
Last Updated: 2025-05-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
NA
21 participants
INTERVENTIONAL
2023-07-13
2025-05-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Patients and methods: twenty one patients were chosen from the Outpatient Clinic in the Oral and Maxillofacial Surgery Department, Faculty of Dentistry, Mansoura University seeking implant placement. Patients were divided randomly and equally into three groups: group I (control group): 7 patients received implants without coating by any materials. Group II \[Hyaluronic acid (HA) group\]: 7 patients received implants coated with HA gel .Group III \[atorvastatin (ATV) group\]: 7 patients received implants coated with ATV gel. Clinical evaluation of implant stability was performed at the time of implant insertion and after 3 and 6 months postoperative. Also, peri-implant pocket depth (PPD) and modified sulcus bleeding index (mSBI) were evaluated. Radiographical evaluation of bone density (BD) was performed immediately and after 6 months postoperatively of implant loading using CBCT. All clinical and radiographic data were subjected to statistical analysis.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Different Surgical Drilling Protocols in Posterior Maxilla
NCT06334081
Using Two Different Attachments in Mandibular Implant Overdenture Cases in Order to Retention and Patient Satisfaction
NCT06678945
Effect of Implant Position on Clinical Outcomes
NCT06166316
Effect of Temporization on the Peri-implant Soft Tissue of Immediate Implants: Randomized Controlled Clinical Trial
NCT03970811
Surface Topography and Color Stability of Implant Supported 3D Printed Provisional Restorations
NCT06947070
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
OTHER
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
hyaluronic acid
\[Hyaluronic acid (HA) group\]: 7 patients received implants coated with HA gel .
implant surgery
surgery
atorvastatin
\[atorvastatin (ATV) group\]: 7 patients received implants coated with ATV gel
implant surgery
surgery
control
group I (control group): 7 patients received implants without coating by any materials.
implant surgery
surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
implant surgery
surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* patients with one or more missing maxillary posterior teeth
* age ranging from 18 to 45 years
* patient's cooperation
* motivation and good oral hygiene
* adequate occlusion (proper interarch space).
Exclusion Criteria
* pregnant individuals
* individuals with any bone diseases that may impede bone healing
* smokers
* individuals who exhibit parafunctional habits like bruxism and clenching.
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Amira attia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Amira attia
assistant professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Amira Attia
Al Mansurah, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
M0103023OS
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.